NFA
PDLI

Nationwide Fund Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Nationwide Fund Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-95,229
Closed -$323K – 3093
2017
Q3 		$323K Sell
95,229
-14,732
-13% -$41K ﹤0.01% 2401
2017
Q2 		$272K Buy
109,961
+4,900
+5% +$11.3K ﹤0.01% 2495
2017
Q1 		$238K Sell
105,061
-5,429
-5% -$12K ﹤0.01% 2509
2016
Q4 		$234K Buy
110,490
+1,537
+1% +$4.29K ﹤0.01% 2531
2016
Q3 		$365K Hold
108,953
– – ﹤0.01% 2329
2016
Q2 		$342K Buy
108,953
+2,713
+3% +$9.05K ﹤0.01% 2352
2016
Q1 		$354K Sell
106,240
-3,300
-3% -$10.3K ﹤0.01% 2272
2015
Q4 		$388K Sell
109,540
-174,293
-61% -$730K ﹤0.01% 2245
2015
Q3 		$1.43M Buy
283,833
+34,300
+14% +$197K 0.01% 1544
2015
Q2 		$1.6M Sell
249,533
-11,315
-4% -$75.8K 0.01% 1570
2015
Q1 		$1.83M Sell
260,848
-5,016
-2% -$36.3K 0.01% 1537
2014
Q4 		$2.05M Sell
265,864
-1,378
-0.5% -$10.9K 0.01% 1397
2014
Q3 		$2M Buy
267,242
+6,776
+3% +$62.9K 0.01% 1439
2014
Q2 		$2.52M Sell
260,466
-27,152
-9% -$242K 0.01% 1353
2014
Q1 		$2.39M Buy
287,618
+178,861
+164% +$1.53M 0.01% 1255
2013
Q4 		$918K Sell
108,757
-3,063
-3% -$25.8K ﹤0.01% 1920
2013
Q3 		$891K Buy
111,820
+5,359
+5% +$43.1K ﹤0.01% 1897
2013
Q2 		$822K Buy
+106,461
New +$830K ﹤0.01% 1770

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Nationwide Fund Advisors's PDLI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2017, closing a stake of 95,229 shares — an estimated $323K sold.

Nationwide Fund Advisors first reported a position in PDLI in Q2 2013 and held it in 18 quarters. The position peaked at $2.52M in Q2 2014. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 95,229 PDL BioPharma, Inc. shares in Q4 2017, an estimated $323K.
  • Nationwide Fund Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's PDL BioPharma, Inc. position peaked at $2.52M in Q2 2014.
  • 187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.